Royal Bank of Canada
OMGA

Royal Bank of Canada’s Omega Therapeutics, Inc. Common Stock OMGA Stock Holding History

Royal Bank of Canada’s Portfolio OMGA Stock Details OMGA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-67
Closed – – 7379
2024
Q4 		$0 Hold
67
– – ﹤0.01% 7367
2024
Q3 		$0 Sell
67
-14,267
-100% -$22.7K ﹤0.01% 7629
2024
Q2 		$30K Buy
14,334
+13,529
+1,681% +$31.9K ﹤0.01% 5900
2024
Q1 		$3K Sell
805
-6,865
-90% -$26.3K ﹤0.01% 6634
2023
Q4 		$24K Buy
7,670
+4,368
+132% +$8.85K ﹤0.01% 6255
2023
Q3 		$8K Buy
3,302
+1,030
+45% +$4.12K ﹤0.01% 6507
2023
Q2 		$12K Buy
2,272
+2,017
+791% +$15.8K ﹤0.01% 6429
2023
Q1 		$2K Hold
255
– – ﹤0.01% 6818
2022
Q4 		$1K Sell
255
-839
-77% -$4.71K ﹤0.01% 7107
2022
Q3 		$6K Buy
1,094
+280
+34% +$1.42K ﹤0.01% 6680
2022
Q2 		$3K Sell
814
-805
-50% -$3K ﹤0.01% 6874
2022
Q1 		$11K Sell
1,619
-289
-15% -$2.95K ﹤0.01% 6919
2021
Q4 		$21K Buy
1,908
+1,085
+132% +$20.6K ﹤0.01% 6790
2021
Q3 		$16K Buy
+823
New +$15.8K ﹤0.01% 6795

Other funds holding OMGA

Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
PS
Principal Securities Des Moines, Iowa $8.31B AUM 21.94% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

Royal Bank of Canada's OMGA Position: Q1 2025 in Review

Royal Bank of Canada sold out of Omega Therapeutics, Inc. Common Stock (OMGA) in Q1 2025, closing a stake of 67 shares.

Royal Bank of Canada first reported a position in OMGA in Q3 2021 and held it in 14 quarters. The position peaked at $30K in Q2 2024. 4 funds tracked by Wall St. Rank hold OMGA as of Q1 2025.

  • Royal Bank of Canada reported no remaining Omega Therapeutics, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Royal Bank of Canada sold 67 Omega Therapeutics, Inc. Common Stock shares in Q1 2025.
  • Royal Bank of Canada first reported a position in Omega Therapeutics, Inc. Common Stock in Q3 2021 and held it in 14 quarters.
  • Royal Bank of Canada's Omega Therapeutics, Inc. Common Stock position peaked at $30K in Q2 2024.
  • 4 funds tracked by Wall St. Rank held Omega Therapeutics, Inc. Common Stock as of Q1 2025.

Based on Royal Bank of Canada's 13F filing for Q1 2025, filed 15 May 2025.